Safety and effectiveness of transforaminal epiduroscopic laser ablation in single level disc disease: A case-control study

Gyu Yeol Ji, Jongsun Lee, Sang Won Lee, Bo Young Cho, Dong Won Ha, Young Mok Park, DongAh Shin

Research output: Contribution to journalArticle

Abstract

Background: The non-operative treatment of herniated intervertebral discs has long been a fundamental challenge. A novel technique of laser ablation to ablate the nucleus pulposus under a transforaminal epiduroscope (TELA system, Lutronics, Seoul, Republic of Korea) was recently developed. Objective: The purpose of this study was to evaluate the safety and effectiveness of transforaminal epiduroscopic laser ablation (TELA) for selective ablation of the nucleus pulposus in single-level disc disease. Study Design: Prospective case control study Setting: Multicenter study Methods: This study included a group of 56 patients who underwent transforaminal epiduroscopic laser ablation (TELA) and 56 patients who underwent selective transforaminal epidural block (STEB) for single-level disc disease. Visual analog scale (VAS), Oswestry Disability Index (ODI), and SF-12 were assessed at admission and at 1, 3, 6, and 12 months postoperatively. Results: The mean VAS of back pain was lower for the TELA group than for the STEB group 12 months postoperative (P < 0.05). The mean ODI was lower in the TELA group than in the STEB group at 12 months postoperatively (P < 0.05). There were no major complications related to the TELA and STEB procedures. Limitations: The primary limitation is a small sample size. The control group was created from a database which was prospectively collected in a different time line. Conclusions: The TELA procedure is superior to the STEB procedure in terms of patients reporting less pain and better quality of life over a year. TELA may be a reasonable alternative to conventional interventions or open surgery in single-level disc disease.

Original languageEnglish
Pages (from-to)E643-E650
JournalPain Physician
Volume21
Issue number6
Publication statusPublished - 2018 Nov 1

Fingerprint

Laser Therapy
Case-Control Studies
Safety
Visual Analog Scale
Intervertebral Disc Displacement
Republic of Korea
Intervertebral Disc
Low Back Pain
Sample Size
Multicenter Studies
Quality of Life
Databases
Prospective Studies
Pain
Control Groups

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Ji, Gyu Yeol ; Lee, Jongsun ; Lee, Sang Won ; Cho, Bo Young ; Ha, Dong Won ; Park, Young Mok ; Shin, DongAh. / Safety and effectiveness of transforaminal epiduroscopic laser ablation in single level disc disease : A case-control study. In: Pain Physician. 2018 ; Vol. 21, No. 6. pp. E643-E650.
@article{b0156ab328b64e948502c9cc7622dedf,
title = "Safety and effectiveness of transforaminal epiduroscopic laser ablation in single level disc disease: A case-control study",
abstract = "Background: The non-operative treatment of herniated intervertebral discs has long been a fundamental challenge. A novel technique of laser ablation to ablate the nucleus pulposus under a transforaminal epiduroscope (TELA system, Lutronics, Seoul, Republic of Korea) was recently developed. Objective: The purpose of this study was to evaluate the safety and effectiveness of transforaminal epiduroscopic laser ablation (TELA) for selective ablation of the nucleus pulposus in single-level disc disease. Study Design: Prospective case control study Setting: Multicenter study Methods: This study included a group of 56 patients who underwent transforaminal epiduroscopic laser ablation (TELA) and 56 patients who underwent selective transforaminal epidural block (STEB) for single-level disc disease. Visual analog scale (VAS), Oswestry Disability Index (ODI), and SF-12 were assessed at admission and at 1, 3, 6, and 12 months postoperatively. Results: The mean VAS of back pain was lower for the TELA group than for the STEB group 12 months postoperative (P < 0.05). The mean ODI was lower in the TELA group than in the STEB group at 12 months postoperatively (P < 0.05). There were no major complications related to the TELA and STEB procedures. Limitations: The primary limitation is a small sample size. The control group was created from a database which was prospectively collected in a different time line. Conclusions: The TELA procedure is superior to the STEB procedure in terms of patients reporting less pain and better quality of life over a year. TELA may be a reasonable alternative to conventional interventions or open surgery in single-level disc disease.",
author = "Ji, {Gyu Yeol} and Jongsun Lee and Lee, {Sang Won} and Cho, {Bo Young} and Ha, {Dong Won} and Park, {Young Mok} and DongAh Shin",
year = "2018",
month = "11",
day = "1",
language = "English",
volume = "21",
pages = "E643--E650",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "6",

}

Safety and effectiveness of transforaminal epiduroscopic laser ablation in single level disc disease : A case-control study. / Ji, Gyu Yeol; Lee, Jongsun; Lee, Sang Won; Cho, Bo Young; Ha, Dong Won; Park, Young Mok; Shin, DongAh.

In: Pain Physician, Vol. 21, No. 6, 01.11.2018, p. E643-E650.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Safety and effectiveness of transforaminal epiduroscopic laser ablation in single level disc disease

T2 - A case-control study

AU - Ji, Gyu Yeol

AU - Lee, Jongsun

AU - Lee, Sang Won

AU - Cho, Bo Young

AU - Ha, Dong Won

AU - Park, Young Mok

AU - Shin, DongAh

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: The non-operative treatment of herniated intervertebral discs has long been a fundamental challenge. A novel technique of laser ablation to ablate the nucleus pulposus under a transforaminal epiduroscope (TELA system, Lutronics, Seoul, Republic of Korea) was recently developed. Objective: The purpose of this study was to evaluate the safety and effectiveness of transforaminal epiduroscopic laser ablation (TELA) for selective ablation of the nucleus pulposus in single-level disc disease. Study Design: Prospective case control study Setting: Multicenter study Methods: This study included a group of 56 patients who underwent transforaminal epiduroscopic laser ablation (TELA) and 56 patients who underwent selective transforaminal epidural block (STEB) for single-level disc disease. Visual analog scale (VAS), Oswestry Disability Index (ODI), and SF-12 were assessed at admission and at 1, 3, 6, and 12 months postoperatively. Results: The mean VAS of back pain was lower for the TELA group than for the STEB group 12 months postoperative (P < 0.05). The mean ODI was lower in the TELA group than in the STEB group at 12 months postoperatively (P < 0.05). There were no major complications related to the TELA and STEB procedures. Limitations: The primary limitation is a small sample size. The control group was created from a database which was prospectively collected in a different time line. Conclusions: The TELA procedure is superior to the STEB procedure in terms of patients reporting less pain and better quality of life over a year. TELA may be a reasonable alternative to conventional interventions or open surgery in single-level disc disease.

AB - Background: The non-operative treatment of herniated intervertebral discs has long been a fundamental challenge. A novel technique of laser ablation to ablate the nucleus pulposus under a transforaminal epiduroscope (TELA system, Lutronics, Seoul, Republic of Korea) was recently developed. Objective: The purpose of this study was to evaluate the safety and effectiveness of transforaminal epiduroscopic laser ablation (TELA) for selective ablation of the nucleus pulposus in single-level disc disease. Study Design: Prospective case control study Setting: Multicenter study Methods: This study included a group of 56 patients who underwent transforaminal epiduroscopic laser ablation (TELA) and 56 patients who underwent selective transforaminal epidural block (STEB) for single-level disc disease. Visual analog scale (VAS), Oswestry Disability Index (ODI), and SF-12 were assessed at admission and at 1, 3, 6, and 12 months postoperatively. Results: The mean VAS of back pain was lower for the TELA group than for the STEB group 12 months postoperative (P < 0.05). The mean ODI was lower in the TELA group than in the STEB group at 12 months postoperatively (P < 0.05). There were no major complications related to the TELA and STEB procedures. Limitations: The primary limitation is a small sample size. The control group was created from a database which was prospectively collected in a different time line. Conclusions: The TELA procedure is superior to the STEB procedure in terms of patients reporting less pain and better quality of life over a year. TELA may be a reasonable alternative to conventional interventions or open surgery in single-level disc disease.

UR - http://www.scopus.com/inward/record.url?scp=85060007472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060007472&partnerID=8YFLogxK

M3 - Article

C2 - 30508995

AN - SCOPUS:85060007472

VL - 21

SP - E643-E650

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 6

ER -